1 paper
Yi Kan Wang, Ludmila Tydlitatova, Jeremy D. Kunz +15
Molecular assays are standard of care for detecting genomic alterations in cancer prognosis and therapy selection but are costly, tissue-destructive and time-consuming. Artificial…